A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

by | Mar 5, 2026 | Clinical Trials | 0 comments

​ Conditions: Biliary Tract Cancer

Interventions: Drug: SHR-A1904 for Injection

Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting Conditions: Biliary Tract Cancer
Interventions: Drug: SHR-A1904 for Injection
Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *